<DOC>
<DOCNO>
EP-0007679
</DOCNO>
<TEXT>
<DATE>
19800206
</DATE>
<IPC-CLASSIFICATIONS>
C07D-409/06 C07D-405/06 A61K-31/4418 C07D-405/00 A61P-1/00 A61K-31/443 C07D-213/53 A61K-31/4402 A61K-31/4409 A61K-31/4427 A61P-1/04 C07D-213/89 A61K-31/44 C07D-409/00 A61K-31/4433 A61K-31/4406 C07D-213/00 
</IPC-CLASSIFICATIONS>
<TITLE>
oxime ethers, processes for their manufacture and pharmaceutical compositions thereof.
</TITLE>
<APPLICANT>
acf chemiefarma nvnl<sep>acf chemiefarma nv<sep>acf chemiefarma nvpostbus 5nl-3600 aa maarssennl<sep>
</APPLICANT>
<INVENTOR>
van zorge jacob adriaan drnl<sep>van zorge, jacob adriaan, dr.<sep>van zorge, jacob adriaan, dr.zouwendijk 19nl-4233 ch ameidenl<sep>
</INVENTOR>
<ABSTRACT>
pharmaceutical compositions having anti-ulcer activity,  containing as an active ingredient a compound of the formula  (i):    wherein het is a pyridinyl group, ar is a phenyl or a 5- or 6-Â­ membered monocyclic heteroaromatic group, r is an alkyl,  alkenyl, alkynyl, cyanoalkyl carbamidoalkyl or aminoalkyl  group, and m and n are each 0 or 1, with the proviso that m + n  is 2, or an n-oxide thereof.  
</ABSTRACT>
</TEXT>
</DOC>
